SC
CNMD icon

Swan Capital’s CONMED CNMD Stock Holding History

Swan Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$495 Hold
14
– – ﹤0.01% 490
2025
Q4 		$568 Hold
14
– – ﹤0.01% 444
2025
Q3 		$658 Hold
14
– – ﹤0.01% 422
2025
Q2 		$729 Hold
14
– – ﹤0.01% 399
2025
Q1 		$845 Hold
14
– – ﹤0.01% 298
2024
Q4 		$958 Hold
14
– – ﹤0.01% 282
2024
Q3 		$1.01K Hold
14
– – ﹤0.01% 265
2024
Q2 		$970 Buy
+14
New +$1.02K ﹤0.01% 227

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Swan Capital's CNMD Position: Q1 2026 in Review

Swan Capital held its CONMED (CNMD) position steady in Q1 2026 at 14 shares worth $495. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Swan Capital first reported a position in CNMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.01K in Q3 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Swan Capital held 14 shares of CONMED worth $495 as of Q1 2026.
  • Swan Capital left its CONMED share count unchanged in Q1 2026.
  • CONMED made up ﹤0.01% of Swan Capital's portfolio in Q1 2026, its #490 holding.
  • Swan Capital first reported a position in CONMED in Q2 2024 and has held it in 8 quarters since.
  • Swan Capital's CONMED position peaked at $1.01K in Q3 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.